Standardization of Heparin

Thromb Haemost 1980; 43(03): 228
DOI: 10.1055/s-0038-1650060

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

L B Jaques

Dept. of Physiology, College of Medicine and College of Dentistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N OWO

References
1 Jorpes E. Heparin: Its Chemistry. Physiology and Application in Medicine. Oxford University Press. London: 1939
2 Jaques LB. Heparin: An Old drug with a new paradigm. Science 1979; 206: 528-533
3 Jaques L B and McDuffie NM. Heparin: The chemical and anticoagulant nature of heparin. Seminars in Thrombosis Hemostasis. 1978; 4: 277-297
4 Lindahl U. Structural basis for the biological effects of heparin. In: Heparin, Structure, Cellular Functions, and Clinical Application. McDuffie NM. (Ed) 167-180 Academic Press, N. Y. C.: 1979
5 Jaques LB, Kavanagh L W and Kuo SH. Variation in chemical parameters and anticoagulant potencies of commercial heparin and its relationship to the problem of heparin standardized for clinical use. Thromb. Res 1973; 3: 295-306
6 Sawyer P, Srinivasan S, Stanczewski B, Ramasamy N, and RamseyW. Electrochemical Aspects of Thrombogenesis – Bioelectrochemistry Old and New. J. Electrochem. Society 1974; 121: 2216-2336
7 Sharnoff JG. Efficacy of heparin. The Lancet. 1973; 1: 258